Cerner Corporations in-depth stock price analysis indicates that the stock price has rallied 3.98% in the past 12 Weeks but analyzing the 6 month chart of the stock, the price of the stock has managed to drop negative and it has dropped down to -20.33% . Looking at the past 52 week period, the stock price is down -6.19% . Relative price strength is a important factor used by wealth management firms while investing in stocks since the indicator compares the stock performance with the overall market. The relative price strength of Cerner Corporation has a negative value of -10.56 compared to overall market performance. Cerner Corporation (NASDAQ:CERN) has tumbled 4.03% during the past week, however, the bigger picture is still very bullish; the stocks have advanced and posted positive gains of 0.29% in the last four weeks. The stocks are negative as compared to the S&P 500 for the past week with a loss of 4.8%. Cerner Corporation (NASDAQ:CERN) has underperformed the index by 1.5% in the last 4 weeks. Investors should watch out for further signals and trade with caution.
Cerner Corporation (NASDAQ:CERN) stock ended Friday session in the red zone in a volatile trading. The stock closed down 2.38 points or 4.42% at $51.5 with 8,307,659 shares getting traded. Post opening the session at $51.5, the shares hit an intraday low of $51.29 and an intraday high of $52.715 and the price was in this range throughout the day. The company has a market cap of $17,484 million and the number of outstanding shares has been calculated to be 339,496,330 shares. The 52-week high of Cerner Corporation (NASDAQ:CERN) is $67.5 and the 52-week low is $47.01.
Cerner Corporation Last issued its quarterly earnings results on Feb 9, 2017. The company reported $0.61 EPS for the quarter. Analyst had a consensus estimate of $0.61. The company had revenue of $1257.00 million for the quarter, compared to analysts expectations of $1262.57 million. The companys revenue was up 7.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.61 EPS.
Several Stock Research Financial Advisors from Investment Banking firms have advised their client and investors on the stock.Cerner Corporation was Downgraded by Oppenheimer to Perform on Feb 10, 2017. Cerner Corporation was Downgraded by Barclays on Jan 19, 2017 to Equal Weight, Lowers Price Target to $ 52 from a previous price target of $63 .Cerner Corporation was Downgraded by Morgan Stanley to Underweight on Dec 13, 2016. Cerner Corporation was Downgraded by Leerink Partners to Mkt Perform on Dec 1, 2016.
Company has reported several Insider transactions to the SEC, on Nov 7, 2016, William D Zollars (director) sold 10,000 shares at 51.50 per share price.On Sep 7, 2016, Linda M Dillman (director) sold 6,000 shares at 64.68 per share price.On Aug 19, 2016, Clifford W Illig (Vice Chairman) sold 325,705 shares at 65.10 per share price.
Cerner Corp. designs, develops, markets, installs and supports information technology and content solutions for healthcare organizations and consumers that are capable of being implemented on an individual, combined or enterprise-wide basis and are accessible over the internet by consumers, physicians and healthcare providers. Cerners integrated suite of solutions enable healthcare providers to improve operating effectiveness, reduce costs and improve the quality of care as measured by clinical outcomes.